NANOREPRO AG (NN6.DE) Stock Fundamental Analysis

FRA:NN6 • DE0006577109

1.545 EUR
+0.08 (+5.46%)
Last: Feb 24, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

5

Taking everything into account, NN6 scores 5 out of 10 in our fundamental rating. NN6 was compared to 65 industry peers in the Health Care Equipment & Supplies industry. No worries on liquidiy or solvency for NN6 as it has an excellent financial health rating, but there are worries on the profitability. NN6 is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year NN6 has reported negative net income.
  • In multiple years NN6 reported negative net income over the last 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: NN6 reported negative operating cash flow in multiple years.
NN6.DE Yearly Net Income VS EBIT VS OCF VS FCFNN6.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2023 2024 0 10M 20M 30M

1.2 Ratios

  • The Return On Assets of NN6 (-4.53%) is worse than 69.23% of its industry peers.
  • NN6 has a Return On Equity of -4.65%. This is in the lower half of the industry: NN6 underperforms 67.69% of its industry peers.
Industry RankSector Rank
ROA -4.53%
ROE -4.65%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NN6.DE Yearly ROA, ROE, ROICNN6.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2023 2024 0 20 -20 40

1.3 Margins

  • The Gross Margin of NN6 (59.26%) is comparable to the rest of the industry.
  • In the last couple of years the Gross Margin of NN6 has declined.
  • NN6 does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 59.26%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y21.24%
GM growth 5Y-10.7%
NN6.DE Yearly Profit, Operating, Gross MarginsNN6.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2023 2024 0 50 -50 100 -100 -150

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. Health

2.1 Basic Checks

  • NN6 does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, NN6 has about the same amount of shares outstanding.
  • Compared to 5 years ago, NN6 has more shares outstanding
  • There is no outstanding debt for NN6. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
NN6.DE Yearly Shares OutstandingNN6.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2023 2024 2M 4M 6M 8M 10M
NN6.DE Yearly Total Debt VS Total AssetsNN6.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2023 2024 20M 40M 60M

2.2 Solvency

  • NN6 has an Altman-Z score of 17.64. This indicates that NN6 is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 17.64, NN6 belongs to the top of the industry, outperforming 96.92% of the companies in the same industry.
  • NN6 has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 17.64
ROIC/WACCN/A
WACC7.45%
NN6.DE Yearly LT Debt VS Equity VS FCFNN6.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2023 2024 0 20M 40M

2.3 Liquidity

  • NN6 has a Current Ratio of 32.26. This indicates that NN6 is financially healthy and has no problem in meeting its short term obligations.
  • NN6 has a better Current ratio (32.26) than 100.00% of its industry peers.
  • A Quick Ratio of 30.32 indicates that NN6 has no problem at all paying its short term obligations.
  • With an excellent Quick ratio value of 30.32, NN6 belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 32.26
Quick Ratio 30.32
NN6.DE Yearly Current Assets VS Current LiabilitesNN6.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2023 2024 20M 40M 60M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 39.13% over the past year.
  • Looking at the last year, NN6 shows a very strong growth in Revenue. The Revenue has grown by 44.10%.
  • NN6 shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 29.69% yearly.
EPS 1Y (TTM)39.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.22%
Revenue 1Y (TTM)44.1%
Revenue growth 3Y-69.83%
Revenue growth 5Y29.69%
Sales Q2Q%37.29%

3.2 Future

  • NN6 is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 41.42% yearly.
  • NN6 is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 104.40% yearly.
EPS Next Y-1%
EPS Next 2Y41.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year232.82%
Revenue Next 2Y104.4%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
NN6.DE Yearly Revenue VS EstimatesNN6.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2023 2024 2025 2026 50M 100M 150M
NN6.DE Yearly EPS VS EstimatesNN6.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2025 -0.05 -0.1 -0.15 -0.2

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for NN6. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NN6.DE Price Earnings VS Forward Price EarningsNN6.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NN6.DE Per share dataNN6.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

  • A more expensive valuation may be justified as NN6's earnings are expected to grow with 41.42% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.42%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 6.98%, NN6 is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 1.14, NN6 pays a better dividend. On top of this NN6 pays more dividend than 98.46% of the companies listed in the same industry.
  • NN6's Dividend Yield is rather good when compared to the S&P500 average which is at 1.80.
Industry RankSector Rank
Dividend Yield 6.98%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
NN6.DE Yearly Dividends per shareNN6.DE Yearly Dividends per shareYearly Dividends per share 2022 2023 0.1 0.2 0.3 0.4

5.3 Sustainability

DPN/A
EPS Next 2Y41.42%
EPS Next 3YN/A
NN6.DE Yearly Income VS Free CF VS DividendNN6.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2023 2024 0 10M 20M

More info and screens

Find the best dividend stocksShow peers with best dividend

NANOREPRO AG

FRA:NN6 (2/24/2026, 7:00:00 PM)

1.545

+0.08 (+5.46%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners9.02%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap19.93M
Revenue(TTM)5.13M
Net Income(TTM)-1.72M
Analysts84
Price Target4.59 (197.09%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.98%
Yearly Dividend0.15
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.89
P/FCF N/A
P/OCF N/A
P/B 0.53
P/tB 0.59
EV/EBITDA N/A
EPS(TTM)-0.14
EYN/A
EPS(NY)0
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.4
BVpS2.89
TBVpS2.63
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -4.53%
ROE -4.65%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 59.26%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y21.24%
GM growth 5Y-10.7%
F-ScoreN/A
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 32.26
Quick Ratio 30.32
Altman-Z 17.64
F-ScoreN/A
WACC7.45%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)39.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.22%
EPS Next Y-1%
EPS Next 2Y41.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)44.1%
Revenue growth 3Y-69.83%
Revenue growth 5Y29.69%
Sales Q2Q%37.29%
Revenue Next Year232.82%
Revenue Next 2Y104.4%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y49.69%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year38.06%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y195%
FCF growth 3Y4.97%
FCF growth 5YN/A
OCF growth 1Y198.6%
OCF growth 3Y6.28%
OCF growth 5YN/A

NANOREPRO AG / NN6.DE FAQ

What is the ChartMill fundamental rating of NANOREPRO AG (NN6.DE) stock?

ChartMill assigns a fundamental rating of 5 / 10 to NN6.DE.


What is the valuation status of NANOREPRO AG (NN6.DE) stock?

ChartMill assigns a valuation rating of 1 / 10 to NANOREPRO AG (NN6.DE). This can be considered as Overvalued.


What is the profitability of NN6 stock?

NANOREPRO AG (NN6.DE) has a profitability rating of 1 / 10.


What is the financial health of NANOREPRO AG (NN6.DE) stock?

The financial health rating of NANOREPRO AG (NN6.DE) is 9 / 10.